Home › Funds › Royce & Associates › BVS
Royce & Associates position in BVS
BIOVENTUS INC · Health Care
Latest position (Q2 2026)1.83M sh
Reported value held$17.31M
Portfolio Weight0.14%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 1.79M | $25.91M | New |
| Q1 2022 | 1.94M | $27.40M | Add |
| Q2 2022 | 1.96M | $13.36M | Add |
| Q3 2022 | 2.10M | $14.67M | Add |
| Q4 2022 | 241.31K | $630 | Reduce |
| Q1 2023 | 50.00K | $54 | Reduce |
| Q2 2023 | 50.00K | $144.50K | Hold |
| Q3 2023 | 50.00K | $165.00K | Hold |
| Q3 2024 | 697.70K | $8.34M | New |
| Q4 2024 | 732.24K | $7.69M | Add |
| Q1 2025 | 892.22K | $8.16M | Add |
| Q2 2025 | 1.09M | $7.23M | Add |
| Q3 2025 | 1.26M | $8.45M | Add |
| Q4 2025 | 1.25M | $9.31M | Reduce |
| Q1 2026 | 1.54M | $14.07M | Add |
| Q2 2026 | 1.83M | $17.31M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BVS
- BlackRock Inc 3.44M sh · $32.44M · Q2 2026
- Vanguard Group 2.98M sh · $22.21M · Q4 2025
- Geode Capital Management 1.37M sh · $12.89M · Q2 2026
- Wellington Management Group 748.36K sh · $7.06M · Q2 2026
- Renaissance Technologies 736.00K sh · $6.95M · Q2 2026
- Goldman Sachs Group 652.37K sh · $6.16M · Q2 2026
- Fidelity Management & Research (FMR) 452.85K sh · $4.27M · Q2 2026
- Northern Trust Corp 443.82K sh · $4.19M · Q2 2026
- Prudential Financial 394.52K sh · $3.72M · Q2 2026
- Charles Schwab Investment Management 391.86K sh · $3.70M · Q2 2026
- AQR Capital Management 326.12K sh · $3.08M · Q2 2026